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BACKGROUND. It is important for clinicians, researchers, and others who shape
public health policy to understand the demographic correlates and psychologic
factors that drive health behaviors, such as screening for early detection of cancer,
particularly among individuals at high risk for developing the disease.
METHODS. One-hundred eleven men whose brothers were diagnosed with prostate
carcinoma completed a computer-assisted telephone interview aimed to assess
their perception of absolute risk and concern about developing prostate carcinoma
over the next 10 years and across their lifetime. Comparisons were made between
selected demographic, behavioral, family pedigree characteristics, and measures of
perceived risk and concern.
RESULTS. The majority of men perceived their personal risk of developing prostate
carcinoma to be  50%. Men who at the time of the interview were younger than
their affected brother were significantly more concerned about prostate carcinoma
and perceived their risk to be higher than men who were older than their brother.
Estimates of personal risk and concern were also uniformly higher among men
with more than one first-degree relative affected with prostate carcinoma com-
pared to men with only one affected first-degree relative. Risk perception and
concern about an impending prostate carcinoma diagnosis were associated with
the use of supplements marketed for prostate health.
CONCLUSIONS. The findings indicated that birth order in relation to a brother
diagnosed with prostate carcinoma is significantly associated with risk perception
and concern in unaffected family members. These results highlight the need for
further study of the familial dynamics and characteristics that drive health behav-
iors and stress importance of public health education to inform men of personal
risk assessment as well as the risks and benefits of screening. These studies
ultimately can contribute to the success of strategies for the primary prevention
and early detection of cancer. Cancer 2004;100:1537– 44.
© 2004 American Cancer Society.
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Prostate carcinoma is the most common cancer affecting U.S. men,and it is estimated 220,900 new cases were diagnosed in 2003. It is
the second leading cause of cancer mortality among men, behind
lung carcinoma, with approximately 29,000 deaths expected this
year.1 Despite the tremendous amount of research devoted to under-
standing the epidemiology of prostate carcinoma, to our knowledge
relatively little is known regarding the etiology of the disease. Family
history has been shown to be an important determinant of risk. Men
with a family history of prostate carcinoma in a first-degree relative
(father, brother, or son) are reported to be two to four times more
likely to develop the disease compared with men with no such histo-
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ry.2 Higher relative risk estimates have been reported
with a greater number of first-degree relatives affect-
ed3,4 and younger age at diagnosis.5,6 It has been es-
timated that 42% of prostate carcinoma cases may be
attributable to hereditary factors.7 Given these statis-
tics, it is particularly important to understand the mo-
tivation that drives men with a family history of pros-
tate carcinoma to pursue health behaviors such as
screening for early detection and the use of supple-
ments or medications for chemoprevention. In the
current study, we evaluated reported risk perception
and concern about prostate carcinoma among men




Subjects are all participants in the University of Mich-
igan’s Prostate Cancer Genetics Project (PCGP), a
large, family-based study of inherited forms of pros-
tate carcinoma. Initially, the PCGP enrolled families
with two or more living affected family members in a
first or second-degree relationship. However, enroll-
ment criteria were later expanded to include men with
prostate carcinoma diagnosed at age  55 years who
were without a family history.
A complete family history of cancer of any type in
first-, second-, and third-degree relatives was ob-
tained from all participants. For each reported case of
prostate carcinoma in a family member, confirmation
of diagnosis was attempted by contacting the relative,
asking if he would also like to participate and if so,
medical records were requested. If the family member
was deceased, a diagnosis of prostate carcinoma was
verified by receipt of a death certificate or by indepen-
dent confirmation of the diagnosis by two or more
relatives.
After enrollment, the affected men (probands)
were phoned to ask them to contact unaffected broth-
ers to become involved in the project. Of the 169
probands contacted, 132 (78%) agreed to participate.
Thirty-seven probands refused to contact their broth-
ers. The reasons given were 1) the brother was not
interested in participating, 2) the brother lived out of
the country, 3) the proband was estranged from
brother, or 4) the brother was in poor health. Further-
more, nine unaffected men declined when contacted
by their sibling. One hundred eleven men (90%) were
contacted by interviewers and completed the tele-
phone survey for a final response rate of 66%. All
protocols were reviewed and approved by institutional
review board of The University of Michigan Medical
School.
Survey Instrument
The current pilot investigation is limited to the unaf-
fected brothers of men with prostate carcinoma who
consented to participate in the PCGP and who agreed
to complete a computer-assisted, telephone survey
using BioDBx software (version 4.0; University of
Michigan, Ann Arbor, MI, 2002). The survey, which is
approximately 20 minutes in length, was designed pri-
marily to assess the use of complementary and alter-
native medicines (CAMs), screening behavior, and risk
perception among men presumed to be at an in-
creased risk for developing prostate carcinoma. The
prevalence of CAM use in this population will be re-
ported in a forthcoming article. However, to illustrate
the influence of risk perception and concern on health
behaviors in these men, an evaluation of the relation
between risk perception and current CAM use is in-
cluded in the current investigation.
Respondents provided information regarding de-
mographic and behavioral characteristics (education,
marital status, household income, occupation, smok-
ing history, and alcohol consumption). Self-reported
race and age were obtained before survey administra-
tion. Participants also provided information concern-
ing history of prostate-specific antigen (PSA) tests,
digital rectal examinations (DREs), and prostate biop-
sies.
Finally, subjects were asked a series of 4 questions
aimed to assess their short-term (10-year) and long-
term (lifetime) absolute risk of developing prostate
carcinoma. The measures, adapted from Diefenbach
et al.8 and Lipkus et al.,9 were constructed to assess
risk perception and concern. Subjects were asked: “On
a scale of 0 to 10, where 0 is certain not to happen and
10 is certain to happen, how likely are you to get
prostate carcinoma in the next 10 years / in your
lifetime?” Men were also asked: “How concerned are
you about getting prostate carcinoma in the next 10
years / in your lifetime?” The response anchors were
a) not at all concerned, b) slightly concerned, c) some-
what concerned, d) concerned, and e) very concerned.
The responses were then assigned numeric values on
a 5-point Likert scale (1, not at all concerned; 5, very
concerned).
Statistical Methods
Data analysis was performed using SAS software (ver-
sion 8.2; Cary, NC). Histograms were plotted to show
the distribution of both short-term and long-term per-
ceived prostate carcinoma risk and concern. Student t
tests were performed according to the Satterthwaite
method to estimate differences in mean risk percep-
1538 CANCER April 1, 2004 / Volume 100 / Number 7
tion and concern among the participants. The tests
compared selected demographic and behavioral char-
acteristics, the number of relatives affected with pros-
tate carcinoma, and age of the participants at the time
of interview in relation to the age at diagnosis of their
brother and their brother’s current age. In families in
which two or more brothers were diagnosed with
prostate carcinoma, the subject’s age was compared
with the youngest of the affected siblings. Pearson
correlation coefficients (r) were calculated to evaluate
the correlations among long-term and short-term risk
perception, long-term and short-term concern, risk
perception and concern, and measures of risk percep-
tion and concern with use of CAMs. Statistical signif-
icance was considered to be P  0.05.
RESULTS
By design, all subjects in the current study had at least
1 brother living with prostate carcinoma and 47% of
these men had  2 affected first-degree relatives. One-
hundred six (95%) of the subjects were white and the
remaining 5 subjects were black. The median age of
the study participants was 53 years (range, 33–78
years; Table 1). Approximately 86% of respondents
were married at the time of interview. The remaining
subjects were either divorced (9%) or single (5%). A
majority of men reported having attended college,
with nearly 30% earning a postgraduate degree. The
majority of subjects (52%) also reported household
incomes of  $75,000 annually. Sixty-two men (56%)
had smoked cigarettes at some point during their life-
time; however, only 15 men reported that they cur-
rently smoked. Among smokers, a majority of men
smoked on average a pack of cigarettes or more per
day. Among former smokers, the mean duration of
time since they had last smoked was 19 years (data not
shown).
The perceived likelihood of developing prostate
carcinoma among the majority of participants was
 50%, corresponding to a score  5 (Fig. 1). Long-
term risk assessment was higher than short-term es-
timates. Similarly,  50% of the subjects also reported
being at least somewhat concerned about developing
prostate carcinoma. However, concern was greater for
lifetime risk of prostate carcinoma compared with
concern over short-term risk (i.e.,  10 years; Fig. 2).
Measures of 10-year and lifetime risk perception were
found to be highly correlated (r  0.74; P  0.0001), as
were short-term and long-term concern (r  0.85; P
 0.0001; Table 2). Responses to risk perception ques-
tions also were found to be significantly correlated
with reported levels of concern (r  0.62 and r  0.53,
respectively, for 10-year and lifetime measures).
Married men were not as concerned about an
impending diagnosis of prostate carcinoma compared
with unmarried men. However, the estimates with
regard to the likelihood of developing the disease were
similar (Table 3). Level of education was unrelated to
reported levels of concern and risk perception.
The mean age of survey participants (54.4 years)
was slightly younger than that of their affected broth-
ers (55.1 years) (Table 4). Men who were younger than
their affected brother reported a significantly higher
estimate of short-term and long-term risk of prostate
TABLE 1




 50 33 (29.7)
50–60 51 (45.9)
 60 27 (24.3)
Marital status
Married 94 (86.2)
Not married 15 (13.8)
Education
 16 yrs 56 (50.9)
16 yrs 54 (49.1)
Household income




One affected first-degree relative 55 (52.9)
 2 affected first-degree relatives 49 (47.1)
Smoking status
Current smoker 15 (13.5)
Nonsmoker 96 (86.5)
FIGURE 1. Risk perception in the brothers of men with prostate carcinoma
(ca). Open squares: short-term risk; solid squares: long-term risk.
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carcinoma compared with brothers who were older
than their affected sibling (P  0.0001 and 0.0002,
respectively). The differences in risk perception were
found to be slightly more apparent when the subject
was younger than their brother at the time of diagno-
sis of prostate carcinoma. Likewise, younger brothers
also reported significantly higher levels of concern
about developing prostate carcinoma, both in the next
10 years and during their lifetime, compared with
older brothers. Estimates of personal risk and reported
levels of concern were uniformly higher among men
with two or more affected first-degree relatives com-
pared with men whose brother was the only first-
degree relative with prostate carcinoma. However, the
differences were not statistically significant (Table 4).
Nevertheless, risk perception and concern among un-
affected brothers were similar between the 21 families
with  3 confirmed affected men and the 66 families
with  3 affected family members (data not shown).
The association between risk perception/concern
and use of CAMs was assessed to highlight how these
factors may affect health behaviors. Correlations be-
tween the perceived probability of developing prostate
carcinoma and CAM use were stronger for short-term
than for long-term risk (Table 5). When the CAMs were
limited to only the vitamins and supplements sug-
gested to be beneficial for prostate health in general or
those that may possess cancer chemopreventive prop-
erties, use also was found to be more highly correlated
with short-term versus long-term risk perception. Life-
time concern was more highly correlated with use of
CAMs compared with concern about a diagnosis
within 10 years (r  0.65 vs. 0.45). However, when the
analysis was restricted to include only the prostate-
related CAMs, concern about developing prostate car-
cinoma in the next 10 years was found to be more
strongly correlated with use compared with lifetime
concern (r  0.96 vs. 0.73).
DISCUSSION
The results of the current study demonstrate that most
men with a family history of prostate carcinoma in a
first-degree relative were concerned about a potential
diagnosis of prostate carcinoma. This concern was
found to be higher for diagnosis over the long term
compared with diagnosis over the short term. Further-
more, a majority of men presumed they had a  50%
chance of developing prostate carcinoma at some
point during their lifetime. Given their family history,
a comparison with the estimated probability of pros-
tate carcinoma would suggest that these men are ac-
curately assessing their personal risk. The likelihood of
developing prostate carcinoma has been estimated in
the general population to be approximately 16.7% or 1
in 6 men.10 Nevertheless, the estimated lifetime risk of
prostate carcinoma in a man with an affected brother
is 56% (calculated by multiplying the lifetime proba-
bility statistic by the relative risk associated with an
affected brother as determined by a recent metaanaly-
sis [3.37]).2 Population-based studies of risk percep-
tion suggest that men tend to overestimate their per-
sonal risk of developing prostate carcinoma.11,12
Clarke et al.11 reported that in a study of 200 men age
45– 60 years, the mean estimate of the probability of
developing prostate carcinoma was 25%, which is
higher than the predicted likelihood (16.7%).11 Data
from the New York Behavioral Risk Factor Surveillance
System indicated that approximately 40% of men sur-
FIGURE 2. Concern about the development of prostate carcinoma (ca) in
unaffected brothers of men with prostate carcinoma. Open squares: short-term
concern; solid squares: long-term concern.
TABLE 2
Correlations between Measures of Short-Term (10-Year) and Long-
















Likelihood of developing prostate carcinoma
In next 10 yrs — 0.74 0.62 —
During lifetime 0.74a — — 0.53
Concern about developing prostate carcinoma
In next 10 yrs 0.62 — — 0.85
During lifetime — 0.53 0.85 —
a All P values  0.0001.
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veyed in 1997 perceived their risk of prostate carci-
noma to be “medium” and “high.” It is interesting to
note that this estimate excludes 30% of the sample
that reported they could not estimate their personal
risk.12
Although studies of risk perception in men with a
family history of prostate carcinoma demonstrate that
they generally are aware of their heightened risk, there
is always a subset of individuals who underestimate
their personal risk. Cormier et al.13 reported that 51%
of men with a family history of prostate carcinoma in
a first-degree relative believed that their probability of
developing the disease was greater than average.
Moreover, although most men (76%) knew that a pos-
itive family history was a risk factor for prostate car-
cinoma, 38% of these men reported their own risk to
be the same as or less than the average man. Similarly,
Miller et al.14 observed that 43% of the first-degree
relatives of men with prostate carcinoma believed
their risk to be the same as or lower than the general
population.
A number of studies have assessed the relation
among risk perception, adherence to screening, and
interest in genetic testing between men and women
with a family history of cancer.15–25 However, to our
knowledge very few have evaluated specific factors
that influence risk perception and concern in those
with an inherited predisposition, particularly with re-
spect to prostate carcinoma.
We observed that unmarried men were more con-
cerned about prostate carcinoma than their married
counterparts, yet personal risk assessments were sim-
ilar. It may be that spouses provide a sense of security
and reduce concern about potential health problems.
Unmarried men likely do not have the same social
support, which may compound the existing anxiety
over a future diagnosis of prostate carcinoma.
To our knowledge, the current study is the first in
TABLE 3
Selected Sociodemographic Characteristics and Risk Perception in Unaffected Brothers of Men with Prostate Carcinoma
Characteristics
Mean reported perception of likelihood of
developing prostate carcinoma
Mean reported level of concern about
developing prostate carcinoma
In next 10 years During lifetime In next 10 yrs During lifetime
Married 4.70 (73)a 5.96 (75) 3.04 (83) 3.34 (83)
Not married 5.50 (8) 5.78 (9) 4.18 (11) 4.36 (11)
P value 0.3954 0.8126 0.006 0.005
College degree or greater 4.88 (40) 5.91 (42) 3.24 (45) 3.56 (45)
Less than a college degree 4.58 (40) 5.90 (41) 3.06 (48) 3.33 (48)
P value 0.5992 0.9968 0.5218 0.4384
a Number responding.
TABLE 4
Risk Perception and Concern in Unaffected Brothers of Men with Prostate Carcinoma: Age of Respondent in Relation to Age of Proband and
Extent of Prostate Carcinoma Family History
Characteristics
Mean reported perception of likelihood
of developing prostate carcinoma
Mean reported level of concern about
developing prostate carcinoma
In next 10 yrs During lifetime In next 10 yrs During lifetime
Respondent is younger than affected brother 5.73 (44)a 6.74 (46) 3.55 (53) 3.91 (53)
Same age or older than affected brother 3.16 (32) 4.49 (33) 2.53 (36) 2.72 (36)
P value  0.0001 0.0002 0.0009  0.0001
Respondent is younger than affected brother at time of diagnosis 6.15 (33) 7.00 (35) 3.86 (37) 4.22 (37)
Same age or older than affected brother at time of diagnosis 3.49 (43) 4.84 (44) 2.62 (52) 2.87 (52)
P value  0.0001 0.0001  0.0001  0.0001
Respondent has two or more affected first-degree relatives 5.10 (31) 6.39 (33) 3.38 (37) 3.68 (37)
One affected first-degree relative 4.25 (43) 5.43 (44) 2.92 (50) 3.20 (50)
P value 0.1576 0.1109 0.1207 0.1116
a Number responding.
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the literature to assess birth order in relation to a
brother diagnosed with prostate carcinoma and risk
perception among unaffected family members. We
observed that subjects who were younger than their
affected brother both at the time of interview and at
diagnosis were more concerned and their perception
of risk was higher than men who were older than their
affected brother. This finding is particularly interest-
ing because we know that older age is a strong pre-
dictor of risk. Among all men, regardless of their ge-
netic predisposition, the incidence of prostate
carcinoma increases dramatically with age (approxi-
mately 1% per year after age 50 years). Seventy percent
of cases are reportedly diagnosed after age 65 years.10
We are uncertain as to why older brothers are not as
concerned about the possibility of an impending di-
agnosis. It may be that men who are older than their
affected brother could mistakenly assume that they
have passed the risk phase for development of pros-
tate carcinoma and could consider themselves to be
no longer at risk. An alternative explanation may be
that older brothers are not as concerned about a di-
agnosis in the future, assuming that they are unlikely
to die of the disease because of the relatively indolent
course of most cases of prostate carcinoma. Most men
diagnosed after age 70 years will die of conditions
unrelated to their prostate carcinoma.26
Men with two or more affected members of their
nuclear family were more concerned and their per-
ceived risk higher than men whose affected brother
was the only first-degree relative affected. The current
study results are comparable to results of what to our
knowledge is the only other study of predictors of
cancer worry and risk perception among men with a
positive family history of prostate carcinoma. Bratt et
al.22 observed perceived risk to be positively correlated
with the number of affected relatives (r  0.23; P
 0.001) and with the number of relatives dying of
prostate carcinoma (P  0.01). The number of deaths
among relatives due to prostate carcinoma also was
found to be correlated with cancer worry.
In the current study, reported levels of both short-
term and long-term concern were found to be signif-
icantly correlated with the estimates of personal risk.
Short-term estimates of both measures were found to
be highly correlated with long-term estimates. These
findings are consistent with similar studies in the lit-
erature on prostate and breast carcinoma.9,22 Bratt et
al.22 reported that subjects who overestimated their
personal risk of prostate carcinoma also reported that
worry over cancer interfered with their lives on a daily
basis. Lipkus et al.9 found that worry about breast
carcinoma was positively correlated with risk percep-
tion among women with and without a family history
of breast carcinoma.
Finally, the observed relation between risk per-
ception and concern with CAM use in the current
study shows that heightened concern and perceived
risk can translate into health behaviors that are in-
tended to prevent future cancer occurrence. Further-
more, the results of the current study suggest that
short-term risk perception and concern may be a bet-
ter predictor of health-related behaviors than per-
ceived risk and worry about prostate carcinoma devel-
opment at some point during one’s lifetime.
There are limitations in the design of the current
study that require careful interpretation of the find-
ings. The small sample of subjects may limit our abil-
ity to detect some findings of potential statistical sig-
nificance. Moreover, because 95% of the study
population was white, we could not evaluate potential
racial differences in risk perception and concern. In
addition,  50% of subjects in the current study re-
ported household incomes of  $75,000 annually and
were well educated. Therefore, the current study re-
sults may not be generalizable to populations in lower
socioeconomic strata. Furthermore, it is possible that,
as participants in a genetic study, these men are more
knowledgeable about their personal risk of prostate
carcinoma. This would limit the generalizability of
these findings to men in the general population or to
men with a family history, but who are unrelated to
anyone participating in a genetic study. Participants in
the current study have not received any specific infor-
mation regarding the personal risk of prostate carci-
noma. Subjects may be knowledgeable of the finding
that family history is a risk factor for prostate carci-
noma. If this were true, one might expect that these
TABLE 5
Correlations between CAM Use and Risk Perception and Concern
Characteristics







Likelihood of developing prostate carcinoma
In next 10 yrs 0.9087 (0.01) 0.8730 (0.02)
During lifetime 0.4684 (0.08) 0.4280 (0.09)
Concern about developing prostate carcinoma
In next 10 yrs 0.4533 (0.08) 0.9627 (0.0004)
During lifetime 0.6562 (0.05) 0.7351 (0.04)
CAM: complementary and alternative medicine.
a Vitamins A, C, and E; beta-carotene; flaxseed oil; finasteride; male hormones; green tea; selenium;
magnesium; soy, and saw palmetto.
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men would report their risk of developing prostate
carcinoma to be higher than the average man. Yet, this
knowledge does not necessarily translate into accurate
risk assessment, as supported by the results by
Cormier et al.13 Information concerning the number
of affected relatives was not reported by participants
in the current survey. Rather, it was provided by the
proband and confirmed by PCGP research personnel.
This may explain the inconsistency in findings relating
risk perception and concern to the number of affected
first-degree family members versus the total number
of affected relatives in a family. Although it is likely
that unaffected men would know the disease status of
close family members, it also is plausible that they are
unaware of the health conditions of more removed
relatives. Men with prostate carcinoma are more likely
to be knowledgeable of other family members who
have the same disease. Finally, once permission was
obtained to contact potential subjects, the response
rate among the unaffected brothers was high (90%).
However, many of the probands would not allow us to
contact their brother, which reduced the overall re-
sponse rate (66%) and introduced the possibility of
selection bias due to nonparticipation.
The results of the current study indicate that a
majority of men with a family history of prostate car-
cinoma estimate their personal risk of developing
prostate carcinoma to be  50% and are concerned
about an impending diagnosis. Risk perception and
concern about a potential diagnosis of prostate carci-
noma appear to be influenced by marital status, the
number of affected first-degree relatives, and the age
of the unaffected man relative to his affected brother.
The latter point may have important implications for
prostate carcinoma education and early detection. It is
critical to recognize that prostate carcinoma is a late-
onset disease that provides an important window of
opportunity for potential clinical intervention through
early detection and modification of risk. Larger studies
are clearly needed, including those of men represent-
ing more diverse populations, to more fully character-
ize the determinants of risk perception and concern
for prostate carcinoma because these perceptions im-
pact important behaviors, including CAM use to im-
prove prostate health.
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